156 related articles for article (PubMed ID: 12823366)
21. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review.
Bouchelouche K; Oehr P
J Urol; 2008 Jan; 179(1):34-45. PubMed ID: 17997425
[TBL] [Abstract][Full Text] [Related]
22. Lymphangiography in genitourinary cancer.
von Eschenbach AC; Jing BS; Wallace S
Urol Clin North Am; 1985 Nov; 12(4):715-23. PubMed ID: 4060353
[TBL] [Abstract][Full Text] [Related]
23. [Accuracy of computed tomography in urological tumour diagnosis (author's transl)].
Latal D; Kuber W; Imhof H; Küster W
Wien Klin Wochenschr; 1981 Jun; 93(13):415-20. PubMed ID: 7269622
[TBL] [Abstract][Full Text] [Related]
24. Fluorodeoxyglucose positron emission tomography in the evaluation of germ cell tumours at relapse.
Hain SF; O'Doherty MJ; Timothy AR; Leslie MD; Harper PG; Huddart RA
Br J Cancer; 2000 Oct; 83(7):863-9. PubMed ID: 10970686
[TBL] [Abstract][Full Text] [Related]
25. Positron emission tomography (PET) in the urooncological evaluation of the small pelvis.
Machtens S; Serth J; Meyer A; Kleinhorst C; Ommer KJ; Herbst U; Kieruij M; Boerner AR
World J Urol; 2007 Aug; 25(4):341-9. PubMed ID: 17624533
[TBL] [Abstract][Full Text] [Related]
26. Ga-67 citrate imaging in tumors of the genito-urinary tract: report of cooperative study.
Sauerbrunn BJ; Andrews GA; Hübner KF
J Nucl Med; 1978 May; 19(5):470-5. PubMed ID: 205635
[TBL] [Abstract][Full Text] [Related]
27. F-18 fluorodeoxyglucose positron emission tomography in the evaluation of distant metastases from renal cell carcinoma.
Majhail NS; Urbain JL; Albani JM; Kanvinde MH; Rice TW; Novick AC; Mekhail TM; Olencki TE; Elson P; Bukowski RM
J Clin Oncol; 2003 Nov; 21(21):3995-4000. PubMed ID: 14581422
[TBL] [Abstract][Full Text] [Related]
28. [Computer tomography for TNM based radiation planning of urological tumours (author's transl].
Ammon J; Karstens JH; Rübben H
Rofo; 1978 Aug; 129(2):253-9. PubMed ID: 151028
[TBL] [Abstract][Full Text] [Related]
29. Utility of
Siva S; Callahan J; Pryor D; Martin J; Lawrentschuk N; Hofman MS
J Med Imaging Radiat Oncol; 2017 Jun; 61(3):372-378. PubMed ID: 28116853
[TBL] [Abstract][Full Text] [Related]
30. Imaging techniques for detection and extent determination of genitourinary cancer.
Boijsen E
Prog Clin Biol Res; 1983; 132D():373-83. PubMed ID: 6685295
[No Abstract] [Full Text] [Related]
31. Clinical role of F-18 fluorodeoxyglucose positron emission tomography for detection and management of renal cell carcinoma.
Ramdave S; Thomas GW; Berlangieri SU; Bolton DM; Davis I; Danguy HT; Macgregor D; Scott AM
J Urol; 2001 Sep; 166(3):825-30. PubMed ID: 11490227
[TBL] [Abstract][Full Text] [Related]
32. FDG in Urologic Malignancies.
Høilund-Carlsen PF; Poulsen MH; Petersen H; Hess S; Lund L
PET Clin; 2014 Oct; 9(4):457-68, vi. PubMed ID: 26050947
[TBL] [Abstract][Full Text] [Related]
33. [Why is PET/CT essential in urooncology?].
Borbély K; Géczi L; Kásler M
Magy Onkol; 2013 Dec; 57(4):282-96. PubMed ID: 24353995
[TBL] [Abstract][Full Text] [Related]
34. [Positron emission tomography (PET) for diagnosis and monitoring of treatment for urological tumors].
Machtens S; Boerner AR; Hofmann M; Knapp WH; Jonas U
Urologe A; 2004 Nov; 43(11):1397-409. PubMed ID: 15502907
[TBL] [Abstract][Full Text] [Related]
35. Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET/CT with pelvic multiparametric MR imaging with endorectal coil.
Kitajima K; Murphy RC; Nathan MA; Froemming AT; Hagen CE; Takahashi N; Kawashima A
J Nucl Med; 2014 Feb; 55(2):223-32. PubMed ID: 24434294
[TBL] [Abstract][Full Text] [Related]
36. Significance of 18F-fluorodeoxyglucose positron-emission tomography/computed tomography for the postoperative surveillance of advanced renal cell carcinoma.
Park JW; Jo MK; Lee HM
BJU Int; 2009 Mar; 103(5):615-9. PubMed ID: 19007371
[TBL] [Abstract][Full Text] [Related]
37. [Value of imaging for lymph node metastases from renal cell, bladder, prostate, penile, and testicular cancers].
Stattaus J; Bockisch A; Forsting M; Müller SP
Urologe A; 2005 Jun; 44(6):614-24. PubMed ID: 15905989
[TBL] [Abstract][Full Text] [Related]
38. [Positron emission tomography (PET): application in urogenital system oncologic diseases].
Lomeña F; Simó M; Setoain X; Pérez G
Arch Esp Urol; 2001; 54(6):649-60. PubMed ID: 11512406
[TBL] [Abstract][Full Text] [Related]
39. PET in prostate and bladder tumors.
Lee ST; Lawrentschuk N; Scott AM
Semin Nucl Med; 2012 Jul; 42(4):231-46. PubMed ID: 22681672
[TBL] [Abstract][Full Text] [Related]
40. [18F]fluoromethylcholine (FCH) positron emission tomography/computed tomography (PET/CT) for lymph node staging of prostate cancer: a prospective study of 210 patients.
Poulsen MH; Bouchelouche K; Høilund-Carlsen PF; Petersen H; Gerke O; Steffansen SI; Marcussen N; Svolgaard N; Vach W; Geertsen U; Walter S
BJU Int; 2012 Dec; 110(11):1666-71. PubMed ID: 22520686
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
